KNBIF (Kane Biotech) FCF Margin %: -1,170.97% (As of Mar. 2026)


What is Kane Biotech FCF Margin %?

Kane Biotech KNBIF +5.19% FCF Margin % is -1,170.97% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 959 Biotechnology companies, Kane Biotech ranks worse than 89.68% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kane Biotech's Free Cash Flow for the three months ended in Mar. 2026 was $-0.36 Mil. Kane Biotech's Revenue for the three months ended in Mar. 2026 was $0.03 Mil. Therefore, Kane Biotech's FCF Margin % for the quarter that ended in Mar. 2026 was -1,170.97%.

As of today, Kane Biotech's current FCF Yield % is -43.48%.

The historical rank and industry rank for Kane Biotech's FCF Margin % or its related term are showing as below:

KNBIF' s FCF Margin % Range Over the Past 10 Years
Min: -4726.19   Med: -559.87   Max: -57.97
Current: -4726.19

During the past 13 years, the highest FCF Margin % of Kane Biotech was -57.97%. The lowest was -4726.19%. And the median was -559.87%.

KNBIF's FCF Margin % is ranked worse than
89.68% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs KNBIF: -4726.19

Kane Biotech FCF Margin % Related Terms

Kane Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Kane Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech FCF Margin % Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -164.41 -1,982.76 -1,431.53 -201.85 -787.74

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -277.78 -3,015.00 -8,483.33 3,400.00 -1,170.97

KNBIF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Kane Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Kane Biotech's FCF Margin % falls into.


Kane Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Kane Biotech's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2.442/0.31
=-787.74 %

Kane Biotech's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.363/0.031
=-1,170.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -1,170.97% mean?
Kane Biotech (KNBIF) has a FCF Margin % of -1,170.97% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kane Biotech and its competitors. According to the industry distribution chart, Kane Biotech ranks #860 out of 959 companies in the Biotechnology industry, placing it in the top 89.7%.
Is Kane Biotech's FCF Margin % too high?
Kane Biotech's current FCF Margin % is -1,170.97%. Based on the distribution chart, Kane Biotech ranks #860 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Kane Biotech's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #860 out of 959 companies for FCF Margin %. This places Kane Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kane Biotech and its competitors. Kane Biotech's current FCF Margin % is -1,170.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current FCF Margin % of -1,170.97%. The current FCF Margin % is -1,170.97%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current FCF Margin % is -1,170.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.